TOKYO (Reuters) - U.S. oil edged lower on Wednesday, after an industry report showed crude stockpiles in the United States rose against expectations, tempering a rally driven by news that another vaccine against COVID-19 had proved effective in trials.
West Texas Intermediate crude was down 14 cents, or 0.
3%, at $44.77 a barrel by 0035 GMT, after rising more than 4% on Tuesday. Brent crude was yet to trade, having risen almost 4% in the previous session.
The contracts closed at their highest since early March on Tuesday, after a three-day.